April 30, 2020
As skincare product demand drives research, established brands have the opportunity to leverage scientific advancements to provide safe and effective...
August 28, 2018
Sirona Biochem (TSXV:SBM) has announced it has received the US$500,0000 payment from Wanbang Biopharmaceuticals for approval by the China and...
July 12, 2018
Sirona Biochem (TSXV:SBM) announced today that partner, Jiangsu Wanbang Biopharmaceuticals, has confirmed the Investigational New Drug (IND) submission to China’s Food...
January 31, 2018
Sirona Biochem (TSXV: SBM) announced that the Company is developing an anti-wrinkle therapy. The compound, LIP-01, was discovered to have a novel mechanism...
October 25, 2017
Sirona Biochem announced it arranged non-brokered private placement for gross proceeds of $535,000.
September 27, 2017
Sirona Biochem announced its French subsidiary TFChem received the final tranche of 1.2 million from a French public investment bank.
September 21, 2017
Sirona Biochem provided an update to shareholders from their chief financial officer Dr. Howard Verrico.